BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 16779701)

  • 21. Towards more effective advanced drug delivery systems.
    Crommelin DJ; Florence AT
    Int J Pharm; 2013 Sep; 454(1):496-511. PubMed ID: 23415662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-silico simulations of advanced drug delivery systems: what will the future offer?
    Siepmann J
    Int J Pharm; 2013 Sep; 454(1):512-6. PubMed ID: 23867986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of nanotechnology in the treatment and diagnosis of gastrointestinal cancers: review of recent patents.
    Prados J; Melguizo C; Perazzoli G; Cabeza L; Carrasco E; Oliver J; Jiménez-Luna C; Leiva MC; Ortiz R; Álvarez PJ; Aranega A
    Recent Pat Anticancer Drug Discov; 2014 Jan; 9(1):21-34. PubMed ID: 23676104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanotechnology and site-targeted drug delivery.
    Petrak K
    J Biomater Sci Polym Ed; 2006; 17(11):1209-19. PubMed ID: 17176746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applications of nanosystems to anticancer drug therapy (Part II. Dendrimers, micelles, lipid-based nanosystems).
    Ruiz ME; Gantner ME; Talevi A
    Recent Pat Anticancer Drug Discov; 2014 Jan; 9(1):99-128. PubMed ID: 23578193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanoparticle technology for drug delivery: from nanoparticles to cutting-edge delivery strategies - part II.
    Shekunov B
    IDrugs; 2005 May; 8(5):402-3. PubMed ID: 15883922
    [No Abstract]   [Full Text] [Related]  

  • 27. Economic and societal dimensions of nanotechnology-enabled drug delivery.
    te Kulve H; Rip A
    Expert Opin Drug Deliv; 2013 May; 10(5):611-22. PubMed ID: 23406414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of systems approaches on biological problems in drug discovery.
    Hood L; Perlmutter RM
    Nat Biotechnol; 2004 Oct; 22(10):1215-7. PubMed ID: 15470453
    [No Abstract]   [Full Text] [Related]  

  • 29. Vaccine manufacturing: challenges and solutions.
    Ulmer JB; Valley U; Rappuoli R
    Nat Biotechnol; 2006 Nov; 24(11):1377-83. PubMed ID: 17093488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of nanobiotechnology on the development of new drug delivery systems.
    Kayser O; Lemke A; Hernández-Trejo N
    Curr Pharm Biotechnol; 2005 Feb; 6(1):3-5. PubMed ID: 15727551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases.
    Andrade F; Rafael D; Videira M; Ferreira D; Sosnik A; Sarmento B
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1816-27. PubMed ID: 23932923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-infectives in the 21st century.
    Clough J
    Drug Discov Today; 2002 Oct; 7(20):1036-8. PubMed ID: 12546891
    [No Abstract]   [Full Text] [Related]  

  • 34. Controlled release technologies for drug delivery.
    Brayden DJ
    Drug Discov Today; 2003 Nov; 8(21):976-8. PubMed ID: 14643159
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug Delivery 2007--New technologies, partnering and strategies for the future.
    Stevenson L
    IDrugs; 2007 Jun; 10(6):388-90. PubMed ID: 17642001
    [No Abstract]   [Full Text] [Related]  

  • 36. Lessons from 54 years of pharmaceutical research.
    Firestone RA
    Nat Rev Drug Discov; 2011 Oct; 10(12):963. PubMed ID: 22036986
    [No Abstract]   [Full Text] [Related]  

  • 37. Improving the translation in Europe of nanomedicines (a.k.a. drug delivery) from academia to industry.
    Eaton MA
    J Control Release; 2012 Dec; 164(3):370-1. PubMed ID: 22721816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chinese medicine industry 4.0:advancing digital pharmaceutical manufacture toward intelligent pharmaceutical manufacture].
    Cheng YY; Qu HB; Zhang BL
    Zhongguo Zhong Yao Za Zhi; 2016 Jan; 41(1):1-5. PubMed ID: 28845630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanotechnology: Future of Oncotherapy.
    Gharpure KM; Wu SY; Li C; Lopez-Berestein G; Sood AK
    Clin Cancer Res; 2015 Jul; 21(14):3121-30. PubMed ID: 26180057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanoscale drug delivery for targeted chemotherapy.
    Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
    Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.